Delivery Order SPE2DB22D3501-SPE2DB24FUC91
- Not listed
- This federal contract award was issued by the Defense Logistics Agency (DLA) to Amerisourcebergen Drug Corp, a subsidiary of Amerisourcebergen Corporation, a leading global pharmaceutical sourcing and distribution services company. The $10,281.49 firm fixed price delivery order is for the provision of REVLIMID 25 MG CAPSULE 21S pharmaceutical products. The contract has no set-aside designation and the performance location is Amerisourcebergen's corporate headquarters in Conshohocken,...
- This federal contract award was issued by the Defense Logistics Agency (DLA) to Amerisourcebergen Drug Corp, a subsidiary of the Amerisourcebergen Corporation, a leading global pharmaceutical sourcing and distribution services company. The $107,912.38 firm fixed price delivery order is for the supply of REVLIMID 10 mg capsule 100s to DLA Troop Support Medical facilities. The contract has a completion date of June 22, 2023 and does not include a set-aside designation. Amerisourcebergen Drug Corp,...
- This federal contract award to Amerisourcebergen Drug Corp, a subsidiary of Amerisourcebergen Corporation, was issued by the Defense Logistics Agency (DLA) Troop Support Medical for the delivery of 4557530338 - REVLIMID 5 MG CAPSULE 100S. The $160,303.95 firm fixed price delivery order contract has a completion date of July 5, 2022 and does not have a set-aside designation. Amerisourcebergen Drug Corp is a prime contractor that has received numerous federal contract awards from DLA to supply...
- This federal contract award was issued by the Defense Logistics Agency (DLA) to Amerisourcebergen Drug Corp, a subsidiary of Amerisourcebergen Corporation, a leading global pharmaceutical sourcing and distribution services company. The contract is a firm fixed price delivery order for the supply of REVLIMID 10 MG Capsules. The award has a ceiling value of $105,612.88 and an ultimate completion date of May 3, 2024. Amerisourcebergen Drug Corp is the prime contractor and there is no set-aside...
- This federal contract award was made by the Defense Logistics Agency (DLA) to Amerisourcebergen Drug Corp, a subsidiary of Amerisourcebergen Corporation, a leading global pharmaceutical sourcing and distribution services company. The award is a firm fixed price delivery order for the supply of REVLIMID 25 MG CAPSULE 100S, a pharmaceutical product, with a potential value of $107,931.18. The contract has a completion date of March 20, 2023. No set-aside designation was used. Amerisourcebergen Drug...
- The Defense Logistics Agency (DLA) Troop Support Medical awarded Amerisourcebergen Drug Corp, a subsidiary of Amerisourcebergen Corporation, a firm fixed price delivery order to supply REVLIMID 10 MG CAPSULE 100S, a pharmaceutical product, with a potential value of $192,510.80. This award was not set aside for any specific business type. Amerisourcebergen Drug Corp has received numerous federal contract awards from DLA to provide pharmaceuticals, medical supplies, and related distribution...
- This federal contract award was issued by the Defense Logistics Agency (DLA) to Amerisourcebergen Drug Corp, a major pharmaceutical distributor, for the supply of REVLIMID 25 MG CAPSULE 21S. The delivery order contract, valued at $18,722.57, is a firm fixed-price arrangement with an ultimate completion date of August 22, 2024. Amerisourcebergen, through its Corporate Office division, will provide these pharmaceutical products to support the healthcare needs of federal agencies and their...
- This federal contract award was issued by the Defense Logistics Agency (DLA) to AmerisourceBergen Drug Corporation, a major pharmaceutical distributor, for the supply of Revlimid 10 mg capsules. The contract is a Delivery Order with a Firm Fixed Price pricing type, has a ceiling value of $24,963.40, and is set to expire on October 21, 2024. This award is likely part of a larger Indefinite Delivery Contract (IDC) that AmerisourceBergen holds with the DLA for the delivery of a comprehensive...
- Amerisourcebergen Drug Corp has received a $56,490.52 firm fixed price delivery order from the Defense Logistics Agency (DLA) Troop Support Medical to supply REVLIMID 10 MG CAPSULE 28S pharmaceutical products. As the prime contractor, Amerisourcebergen Drug Corp will deliver the specified medications to DLA Troop Support Medical facilities in support of military treatment programs. This delivery order was awarded against an indefinite delivery contract held by Amerisourcebergen Drug Corp's...
- This is a delivery order awarded by the Defense Logistics Agency (DLA) Troop Support Medical to Amerisourcebergen Drug Corp, a subsidiary of Amerisourcebergen Corporation, as the prime contractor. The $106,869.73 firm fixed price contract is for the delivery of REVLIMID 10 MG CAPSULE 100S, a pharmaceutical product, to support military treatment programs and facilities. The contract has a period of performance through March 31, 2022 and does not have a set-aside designation. Amerisourcebergen...
- SPE2DB22D3501Indefinite Delivery Contract
- SPE2DB22D3501-SPE2DB24FUC91Delivery Order
This federal contract award was issued by the Defense Logistics Agency (DLA) to Amerisourcebergen Drug Corp, a subsidiary of Amerisourcebergen Corporation, a leading global pharmaceutical sourcing and distribution services company. The contract is a firm fixed price delivery order to supply Revlimid 10 mg capsules, a specialty pharmaceutical product, with a potential value of $27,859.78. The contract has a completion date of February 1, 2024. Amerisourcebergen Drug Corp, through its Corporate Office division, has been awarded multiple federal contracts by the DLA to provide pharmaceuticals, medical supplies, and related distribution services in support of military treatment programs and facilities. This contract does not have a set-aside designation. The performance location is Amerisourcebergen's corporate headquarters in Conshohocken, Pennsylvania.
Mod # | Description | ReasonForModification | Federal Obligation | Date |
|---|---|---|---|---|
| Not listed | Not listed | $27.9k | 1/10/24 |